CASM Pengajuan SEC - CAS Medical Systems, Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

764579

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to CAS Medical Systems, Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

April 29, 2019	15-12G	CASM / CAS Medical Systems, Inc. 15-12G 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 0-13839 CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as speci
April 22, 2019	SC 13D/A	CASM / CAS Medical Systems, Inc. / Thomas, McNerney & Partners II L.P. - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
April 22, 2019	SC 13D/A	CASM / CAS Medical Systems, Inc. / Patton Thomas M - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No.
April 18, 2019	S-8 POS	CASM / CAS Medical Systems, Inc. S-8 POS S-8 POS Registration No. 333-226641 Registration No. 333-213018 Registration No. 333-197956 Registration No. 333-190582 Registration No. 333-176528 Registration No. 333-160347 Registration No. 333-160346 Registration No. 333-116349 Registration No. 333-116348 Registration No. 333-47258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-
April 18, 2019	S-8 POS	CASM / CAS Medical Systems, Inc. S-8 POS S-8 POS Registration No. 333-226641 Registration No. 333-213018 Registration No. 333-197956 Registration No. 333-190582 Registration No. 333-176528 Registration No. 333-160347 Registration No. 333-160346 Registration No. 333-116349 Registration No. 333-116348 Registration No. 333-47258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-
April 18, 2019	S-8 POS	CASM / CAS Medical Systems, Inc. S-8 POS S-8 POS Registration No. 333-226641 Registration No. 333-213018 Registration No. 333-197956 Registration No. 333-190582 Registration No. 333-176528 Registration No. 333-160347 Registration No. 333-160346 Registration No. 333-116349 Registration No. 333-116348 Registration No. 333-47258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-
April 18, 2019	S-8 POS	CASM / CAS Medical Systems, Inc. S-8 POS S-8 POS Registration No. 333-226641 Registration No. 333-213018 Registration No. 333-197956 Registration No. 333-190582 Registration No. 333-176528 Registration No. 333-160347 Registration No. 333-160346 Registration No. 333-116349 Registration No. 333-116348 Registration No. 333-47258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-
April 18, 2019	S-8 POS	CASM / CAS Medical Systems, Inc. S-8 POS S-8 POS Registration No. 333-226641 Registration No. 333-213018 Registration No. 333-197956 Registration No. 333-190582 Registration No. 333-176528 Registration No. 333-160347 Registration No. 333-160346 Registration No. 333-116349 Registration No. 333-116348 Registration No. 333-47258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-
April 18, 2019	S-8 POS	CASM / CAS Medical Systems, Inc. S-8 POS S-8 POS Registration No. 333-226641 Registration No. 333-213018 Registration No. 333-197956 Registration No. 333-190582 Registration No. 333-176528 Registration No. 333-160347 Registration No. 333-160346 Registration No. 333-116349 Registration No. 333-116348 Registration No. 333-47258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-
April 18, 2019	S-8 POS	CASM / CAS Medical Systems, Inc. S-8 POS S-8 POS Registration No. 333-226641 Registration No. 333-213018 Registration No. 333-197956 Registration No. 333-190582 Registration No. 333-176528 Registration No. 333-160347 Registration No. 333-160346 Registration No. 333-116349 Registration No. 333-116348 Registration No. 333-47258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-
April 18, 2019	S-8 POS	CASM / CAS Medical Systems, Inc. S-8 POS S-8 POS Registration No. 333-226641 Registration No. 333-213018 Registration No. 333-197956 Registration No. 333-190582 Registration No. 333-176528 Registration No. 333-160347 Registration No. 333-160346 Registration No. 333-116349 Registration No. 333-116348 Registration No. 333-47258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-
April 18, 2019	S-8 POS	CASM / CAS Medical Systems, Inc. S-8 POS S-8 POS Registration No. 333-226641 Registration No. 333-213018 Registration No. 333-197956 Registration No. 333-190582 Registration No. 333-176528 Registration No. 333-160347 Registration No. 333-160346 Registration No. 333-116349 Registration No. 333-116348 Registration No. 333-47258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-
April 18, 2019	S-8 POS	CASM / CAS Medical Systems, Inc. S-8 POS S-8 POS Registration No. 333-226641 Registration No. 333-213018 Registration No. 333-197956 Registration No. 333-190582 Registration No. 333-176528 Registration No. 333-160347 Registration No. 333-160346 Registration No. 333-116349 Registration No. 333-116348 Registration No. 333-47258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-
April 18, 2019	POS AM	CASM / CAS Medical Systems, Inc. POS AM POS AM Registration No. 333-214614 Registration No. 333-188844 Registration No. 333-176560 Registration No. 333-168585 Registration No. 333-135158 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-214614 FORM S-3 REGISTRATION STATEMENT NO. 333-188844 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-3 REGISTRATI
April 18, 2019	POS AM	CASM / CAS Medical Systems, Inc. POS AM POS AM Registration No. 333-214614 Registration No. 333-188844 Registration No. 333-176560 Registration No. 333-168585 Registration No. 333-135158 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-214614 FORM S-3 REGISTRATION STATEMENT NO. 333-188844 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-3 REGISTRATI
April 18, 2019	POS AM	CASM / CAS Medical Systems, Inc. POS AM POS AM Registration No. 333-214614 Registration No. 333-188844 Registration No. 333-176560 Registration No. 333-168585 Registration No. 333-135158 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-214614 FORM S-3 REGISTRATION STATEMENT NO. 333-188844 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-3 REGISTRATI
April 18, 2019	SC TO-I/A	CASM / CAS Medical Systems, Inc. AMENDMENT NO. 2 TO FORM SC TO-I SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
April 18, 2019	POS AM	CASM / CAS Medical Systems, Inc. POS AM POS AM Registration No. 333-214614 Registration No. 333-188844 Registration No. 333-176560 Registration No. 333-168585 Registration No. 333-135158 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-214614 FORM S-3 REGISTRATION STATEMENT NO. 333-188844 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-3 REGISTRATI
April 18, 2019	POS AM	CASM / CAS Medical Systems, Inc. POS AM POS AM Registration No. 333-214614 Registration No. 333-188844 Registration No. 333-176560 Registration No. 333-168585 Registration No. 333-135158 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-214614 FORM S-3 REGISTRATION STATEMENT NO. 333-188844 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-3 REGISTRATI
April 18, 2019	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vote of Security Holders 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2019 CAS MEDICAL SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commiss
April 18, 2019	EX-3.1	Amended and Restated Certificate of Incorporation of CAS Medical Systems, Inc. Filed herewith. EX-3.1 2 d678963dex31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CAS MEDICAL SYSTEMS, INC. FIRST: The name of the Corporation is CAS Medical Systems, Inc. (the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is 1209 Orange Street, Wilmington, County of New Castle, Delaware 19801. The name of its registered ag
April 18, 2019	EX-3.2	Second Amended and Restated Bylaws of CAS Medical Systems, Inc. Filed herewith. EX-3.2 3 d678963dex32.htm EX-3.2 Exhibit 3.2 SECOND AMENDED AND RESTATED BYLAWS OF CAS MEDICAL SYSTEMS, INC. ARTICLE I Meeting of Stockholders Section 1.1. Annual Meetings. If required by applicable law, an annual meeting of stockholders shall be held for the election of directors at such date, time and place, if any, either within or without the State of Delaware, as may be designated by resoluti
April 18, 2019	SC 13D/A	CASM / CAS Medical Systems, Inc. / Edwards Lifesciences Holding, Inc. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
April 9, 2019	SC TO-I/A	CASM / CAS Medical Systems, Inc. AMENDMENT NO. 1 TO SCHEDULE TO SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
April 9, 2019	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2019 CAS MEDICAL SYSTEMS, INC.
April 9, 2019	DEFA14A	CASM / CAS Medical Systems, Inc. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2019 CAS MEDICAL SYSTEMS, INC.
March 29, 2019	SC 13G	CASM / CAS Medical Systems, Inc. / MMCAP International Inc. SPC Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 CAS MEDICAL SYSTEMS INC.
March 26, 2019	DEFA14A	CASM / CAS Medical Systems, Inc. DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material under §240.
March 25, 2019	10-K	CASM / CAS Medical Systems, Inc. FORM 10K DATED DECEMBER 31, 2018 (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑K Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year ended December 31, 2018 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
March 25, 2019	EX-2.1	Subsidiaries of the Registrant EX-2.1 2 exh21-118299.htm SUBSIDIARIES OF THE REGISTRANT EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT Statcorp, Inc., a Delaware corporation
March 15, 2019	EX-99.(A)(1)(I)	Offer to Purchase for Cash All Outstanding Options to Purchase Shares of CAS Medical Systems, Inc. Common Stock THE TENDER OFFER AND WITHDRAWAL RIGHTS DESCRIBED BELOW WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON APRIL 17, 2019 UNLESS THE TENDER O Exhibit (a)(1)(i) Offer to Purchase for Cash All Outstanding Options to Purchase Shares of CAS Medical Systems, Inc.
March 15, 2019	SC TO-I	CASM / CAS Medical Systems, Inc. SC TO-I SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 CAS MEDICAL SYSTEMS, INC.
March 15, 2019	EX-99.(A)(1)(III)	FORM OF NOTICE OF WITHDRAWAL CAS MEDICAL SYSTEMS, INC. WITHDRAWAL OF PREVIOUSLY TENDERED OPTIONS PURSUANT TO THE OFFER TO PURCHASE DATED MARCH 15, 2019, THE WITHDRAWAL RIGHTS DESCRIBED BELOW WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON APRIL 17, EX-99.(A)(1)(III) 4 tv516231exa1iii.htm EXHIBIT (A)(1)(III) Exhibit (a)(1)(iii) FORM OF NOTICE OF WITHDRAWAL CAS MEDICAL SYSTEMS, INC. WITHDRAWAL OF PREVIOUSLY TENDERED OPTIONS PURSUANT TO THE OFFER TO PURCHASE DATED MARCH 15, 2019, THE WITHDRAWAL RIGHTS DESCRIBED BELOW WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON APRIL 17, 2019, UNLESS THE OFFER IS EXTENDED All terms used in this withdrawal l
March 15, 2019	EX-99.(A)(1)(II)	CAS MEDICAL SYSTEMS, INC. ELECTION TO TENDER ELIGIBLE OPTIONS PURSUANT TO THE OFFER TO PURCHASE, DATED MARCH 15, 2019 EX-99.(A)(1)(II) 3 tv516231exa1ii.htm EXHIBIT (A)(1)(II) Exhibit (a)(1)(ii) CAS MEDICAL SYSTEMS, INC. ELECTION TO TENDER ELIGIBLE OPTIONS PURSUANT TO THE OFFER TO PURCHASE, DATED MARCH 15, 2019 To: CAS MEDICAL SYSTEMS, INC. I have received and read the Offer to Purchase, dated March 15, 2019, and this Election to Tender Eligible Options (the “election form” which, together with the Offer to Purcha
March 15, 2019	EX-99.(A)(1)(IV)	[CAS MEDICAL LETTERHEAD] tv516231-sctoi_DIV_04-exa1iv - none - 0.8857762s Exhi
March 13, 2019	SC TO-C	CASM / CAS Medical Systems, Inc. SCHEDULE TO TABLE OF CONTENTS SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 CAS MEDICAL SYSTEMS, INC.
March 13, 2019	DEFM14A	CASM / CAS Medical Systems, Inc. DEFINITIVE PROXY STATEMENT TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under §240.
March 12, 2019	SC TO-C	CASM / CAS Medical Systems, Inc. SC TO-C SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 CAS MEDICAL SYSTEMS, INC.
March 12, 2019	EX-10.1	Form of Option Termination Agreement EX-10.1 2 tv51596910-1.htm EXHIBIT 10.1 Exhibit 10.1 OPTION TERMINATION AGREEMENT THIS OPTION TERMINATION AGREEMENT (this “Agreement”) is made as of , 2019, by and between the undersigned (the “Option Holder”) and CAS Medical Systems, Inc., a Delaware corporation (the “Company”). Capitalized terms used herein but not otherwise defined shall have the meaning ascribed to them in the Merger Agreement
March 12, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 tv5159698k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2019 CAS MEDICAL SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-1
March 12, 2019	EX-10.2	Restricted Stock Termination agreement between CAS Medical Systems, Inc. and Thomas M. Patton EX-10.2 3 tv51596910-2.htm EXHIBIT 10.2 Exhibit 10.2 RESTRICTED STOCK TERMINATION AGREEMENT THIS RESTRICTED STOCK TERMINATION AGREEMENT (this “Agreement”) is made as of March 12, 2019, by and between the undersigned (the “Grantee”) and CAS Medical Systems, Inc., a Delaware corporation (the “Company”). Capitalized terms used herein but not otherwise defined shall have the meaning ascribed to them i
March 12, 2019	DEFA14A	CASM / CAS Medical Systems, Inc. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2019 CAS MEDICAL SYSTEMS, INC.
March 12, 2019	EX-10.2	Restricted Stock Termination agreement between CAS Medical Systems, Inc. and Thomas M. Patton EX-10.2 3 tv51596910-2.htm EXHIBIT 10.2 Exhibit 10.2 RESTRICTED STOCK TERMINATION AGREEMENT THIS RESTRICTED STOCK TERMINATION AGREEMENT (this “Agreement”) is made as of March 12, 2019, by and between the undersigned (the “Grantee”) and CAS Medical Systems, Inc., a Delaware corporation (the “Company”). Capitalized terms used herein but not otherwise defined shall have the meaning ascribed to them i
March 12, 2019	EX-10.1	Form of Option Termination Agreement EX-10.1 2 tv51596910-1.htm EXHIBIT 10.1 Exhibit 10.1 OPTION TERMINATION AGREEMENT THIS OPTION TERMINATION AGREEMENT (this “Agreement”) is made as of , 2019, by and between the undersigned (the “Option Holder”) and CAS Medical Systems, Inc., a Delaware corporation (the “Company”). Capitalized terms used herein but not otherwise defined shall have the meaning ascribed to them in the Merger Agreement
March 1, 2019	SC TO-C	CASM / CAS Medical Systems, Inc. SC TO-C SC TO-C 1 tv515193-sctoc.htm SC TO-C TABLE OF CONTENTS SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 CAS MEDICAL SYSTEMS, INC. (Name of Subject Company (Issuer)) CAS MEDICAL SYSTEMS, INC. (Name of Filing Person (Offeror and Issuer)) Options to Purchase Common Stock, Par Value $0.0
March 1, 2019	PREM14A	CASM / CAS Medical Systems, Inc. PRELIMINARY PROXY STATEMENT TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under §240.
February 21, 2019	SC 13D	CASM / CAS Medical Systems, Inc. / Edwards Lifesciences Holding, Inc. - SC 13D Activist Investment SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
February 14, 2019	SC 13G	CASM / CAS Medical Systems, Inc. / ACUTA CAPITAL PARTNERS, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CAS MEDICAL SYSTEMS, INC. (Name of Issuer) COMMON STOCK, PAR $0.004 (Title of Class of Securities) 124769209 (CUSIP Number) ACUTA CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 (Name, Address and Telephone Number of Person Authorize
February 13, 2019	EX-99.6	Voting Agreement, dated February 11, 2018, by and between Thomas, McNerney & Partners II, L.P. and Edwards Lifesciences Holding, Inc. Exhibit 6 VOTING AGREEMENT This VOTING AGREEMENT, dated as of February 11, 2019 (this “Agreement”), is made and entered into by and between Edwards Lifesciences Holding, Inc.
February 13, 2019	SC 13G/A	CASM / CAS Medical Systems, Inc. / Long Focus Capital Management, Llc - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* CAS MEDICAL SYSTEMS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 124769209 (CUSIP Number) Long Focus Capital Management LLC 207 Calle Del Parque A&M Tower, 8th Floor San Juan, PR 00912 (787) 333-0240 (Name, Address and Telephone N
February 13, 2019	EX-99.8	Voting Agreement, dated February 11, 2018, by and between TMP Associates II, L.P. and Edwards Lifesciences Holding, Inc. Exhibit 8 VOTING AGREEMENT This VOTING AGREEMENT, dated as of February 11, 2019 (this “Agreement”), is made and entered into by and between Edwards Lifesciences Holding, Inc.
February 13, 2019	EX-99.7	Voting Agreement, dated February 11, 2018, by and between TMP Nominee II, LLC and Edwards Lifesciences Holding, Inc. EX-99.7 4 tv513444ex99-7.htm EXHIBIT 99.7 Exhibit 7 VOTING AGREEMENT This VOTING AGREEMENT, dated as of February 11, 2019 (this “Agreement”), is made and entered into by and between Edwards Lifesciences Holding, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder (“Stockholder”) of CAS Medical Systems, Inc., a Delaware corporation (the “Company”). Parent and Stockholder are re
February 13, 2019	EX-99.5	Voting Agreement, dated February 11, 2018, by and between James Thomas and Edwards Lifesciences Holding, Inc. EX-99.5 2 tv513444ex99-5.htm EXHIBIT 5 Exhibit 5 VOTING AGREEMENT This VOTING AGREEMENT, dated as of February 11, 2019 (this “Agreement”), is made and entered into by and between Edwards Lifesciences Holding, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder (“Stockholder”) of CAS Medical Systems, Inc., a Delaware corporation (the “Company”). Parent and Stockholder are refer
February 13, 2019	SC 13D/A	CASM / CAS Medical Systems, Inc. / Thomas, McNerney & Partners II L.P. - AMENDMENT TO SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
February 12, 2019	DEFA14A	CASM / CAS Medical Systems, Inc. DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 12, 2019	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K 1 tv5131108k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2019 CAS MEDICAL SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation)
February 12, 2019	EX-99.1	VOTING AGREEMENT Exhibit 99.1 VOTING AGREEMENT This VOTING AGREEMENT, dated as of February 11, 2019 (this “Agreement”), is made and entered into by and between Edwards Lifesciences Holding, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder (“Stockholder”) of CAS Medical Systems, Inc., a Delaware corporation (the “Company”). Parent and Stockholder are referred to individually as a “Party” and
February 12, 2019	EX-3.1	Amendment to Amended and Restated Bylaws Exhibit 3.1 Amendment to the Amended and Restated Bylaws of CAS Medical Systems, Inc. This Amendment to the Amended and Restated Bylaws of CAS Medical Systems, Inc. (the “corporation”) is dated this 11th day of February, 2019. WITNESSETH WHEREAS, the corporation is governed, in part, by the Amended and Restated Bylaws of the corporation; and WHEREAS, pursuant to and in accordance with Section 5.1
February 12, 2019	EX-99.2	EDWARDS LIFESCIENCES ENTERS INTO AGREEMENT TO ACQUIRE CASMED Exhibit 99.2 Edwards Lifesciences Corporation One Edwards Way Irvine, CA USA 92614 Phone: 949.250.2500 Fax: 949.250.2525 www.edwards.com FOR IMMEDIATE RELEASE Media Contact: Sarah Huoh, 949-250-5070 Investor Contact: David K. Erickson, 949-250-6826 EDWARDS LIFESCIENCES ENTERS INTO AGREEMENT TO ACQUIRE CASMED IRVINE, Calif., and BRANFORD, Conn., Feb. 12, 2019 — Edwards Lifesciences Corporation (NYS
February 12, 2019	EX-2.1	Agreement and Plan of Merger dated as of February 11, 2019 by and among CAS Medical Systems, Inc., Edwards Lifesciences Holding, Inc., and Crown Merger Sub, Inc.* EX-2.1 2 tv513110ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among EDWARDS LIFESCIENCES HOLDING, INC., CROWN MERGER SUB, INC. and CAS MEDICAL SYSTEMS, INC., Dated as of February 11, 2019 table of contents Page Article I THE MERGER 2 Section 1.1. The Merger 2 Section 1.2. The Closing 2 Section 1.3. Effective Time 2 Section 1.4. Certificate of Incorporatio
February 12, 2019	EX-2.1	Agreement and Plan of Merger dated as of February 11, 2019 by and among CAS Medical Systems, Inc., Edwards Lifesciences Holding, Inc., and Crown Merger Sub, Inc.* Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among EDWARDS LIFESCIENCES HOLDING, INC., CROWN MERGER SUB, INC. and CAS MEDICAL SYSTEMS, INC., Dated as of February 11, 2019 table of contents Page Article I THE MERGER 2 Section 1.1. The Merger 2 Section 1.2. The Closing 2 Section 1.3. Effective Time 2 Section 1.4. Certificate of Incorporation: Bylaws 2 Section 1.5. Board of Direc
February 12, 2019	EX-99.2	Joint Press Release dated February 12, 2019 EX-99.2 5 tv513110ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Edwards Lifesciences Corporation One Edwards Way Irvine, CA USA 92614 Phone: 949.250.2500 Fax: 949.250.2525 www.edwards.com FOR IMMEDIATE RELEASE Media Contact: Sarah Huoh, 949-250-5070 Investor Contact: David K. Erickson, 949-250-6826 EDWARDS LIFESCIENCES ENTERS INTO AGREEMENT TO ACQUIRE CASMED IRVINE, Calif., and BRANFORD, Conn., Feb. 12, 20
February 12, 2019	EX-3.1	Amendment to Amended and Restated Bylaws Exhibit 3.1 Amendment to the Amended and Restated Bylaws of CAS Medical Systems, Inc. This Amendment to the Amended and Restated Bylaws of CAS Medical Systems, Inc. (the “corporation”) is dated this 11th day of February, 2019. WITNESSETH WHEREAS, the corporation is governed, in part, by the Amended and Restated Bylaws of the corporation; and WHEREAS, pursuant to and in accordance with Section 5.1
February 12, 2019	DEFA14A	CASM / CAS Medical Systems, Inc. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2019 CAS MEDICAL SYSTEMS, INC.
February 12, 2019	EX-99.1	Form of Voting Agreement EX-99.1 4 tv513110ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VOTING AGREEMENT This VOTING AGREEMENT, dated as of February 11, 2019 (this “Agreement”), is made and entered into by and between Edwards Lifesciences Holding, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder (“Stockholder”) of CAS Medical Systems, Inc., a Delaware corporation (the “Company”). Parent and Stockholder are
February 12, 2019	SC 13D/A	CASM / CAS Medical Systems, Inc. / Patton Thomas M - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment SC 13D/A 1 tv513271sc13da.htm AMENDMENT NO. 1 TO SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* CAS Medical Systems, Inc. (Name of Issuer) Common Stock, par value $0.004 per share (Title of Class of Securities) 124769 20 9 (CUSIP Number) Mr. Thomas M. Patton c/o CAS Medical Systems, Inc. 44 East Indus
January 3, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): January 3, 2019 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Incorporation) (Commission Fil
January 3, 2019	EX-99.1	CASMED Reports Preliminary Net Sales for the 2018 Fourth Quarter and Full Year Record Q4 FORE-SIGHT® cerebral oximetry sales drive 18% full-year FORE-SIGHT sales growth Introduces 2019 FORE-SIGHT sales guidance EXHIBIT 99.1 CASMED Reports Preliminary Net Sales for the 2018 Fourth Quarter and Full Year Record Q4 FORE-SIGHT® cerebral oximetry sales drive 18% full-year FORE-SIGHT sales growth Introduces 2019 FORE-SIGHT sales guidance BRANFORD, Conn., Jan. 03, 2019 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, reports prel
October 31, 2018	EX-99.1	CASMED Reports Third-Quarter 2018 Financial Results FORE-SIGHT® sales increase 20%; sensor sales up 22% on 20% growth in the U.S.; operating loss narrows by 25% Conference Call Begins at 10:00 a.m. Eastern Time Today EXHIBIT 99.1 CASMED Reports Third-Quarter 2018 Financial Results FORE-SIGHT® sales increase 20%; sensor sales up 22% on 20% growth in the U.S.; operating loss narrows by 25% Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ: CASM) (“CASMED” or the “Company”), a leader in medical products for non-invasive pati
October 31, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 f8k103118.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): October 31, 2018 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of
October 31, 2018	10-Q	CASM / CAS Medical Systems, Inc. FORM 10Q DATED SEPTEMBER 30, 2018 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑Q Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2018 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
August 7, 2018	EX-4.4	CAS Medical Systems, Inc. 2018 Equity Incentive Plan (23) EXHIBIT 4.4 CAS MEDICAL SYSTEMS, INC. 2018 EQUITY INCENTIVE PLAN Section 1. Purpose. The purposes of this CAS Medical Systems, Inc. 2018 Equity Incentive Plan (the "Plan") are (1) to make available to key employees, directors and consultants certain compensatory arrangements related to the growth in value of the common stock of the Company so as to generate an increased incentive to contribute to
August 7, 2018	S-8	CASM / CAS Medical Systems, Inc. FORM S-8 DATED AUGUST 7, 2018 S-8 1 cas-s818230.htm FORM S-8 DATED AUGUST 7, 2018 As filed with the Securities and Exchange Commission on August 7, 2018 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06-1123096 (State or
August 2, 2018	EX-99.1	CASMED Reports Second Quarter 2018 Financial Results Achieves 20% U.S. FORE-SIGHT® sales growth, expands gross margin, narrows operating loss Conference Call Begins at 10:00 a.m. Eastern Time Today EXHIBIT 99.1 CASMED Reports Second Quarter 2018 Financial Results Achieves 20% U.S. FORE-SIGHT® sales growth, expands gross margin, narrows operating loss Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Aug. 02, 2018 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ: CASM) (“CASMED” or the “Company”), a leader in medical products for non-invasive patient monitoring of t
August 2, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 2, 2018 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Incorporation) (Commission File
August 2, 2018	10-Q	CASM / CAS Medical Systems, Inc. FORM 10Q DATED JUNE 30, 2018 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑Q Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2018 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
June 22, 2018	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2018 CAS MEDICAL SYSTEMS, INC.
May 25, 2018	SD	CASM / CAS Medical Systems, Inc. CAS MEDICAL SYSTEMS - FORM SD SD 1 cas-sd18211.htm CAS MEDICAL SYSTEMS - FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 44 East Industrial Road,
May 25, 2018	EX-1.01	Conflict Minerals Report of CAS Medical Systems, Inc. EX-1.01 2 exh1-0118211.htm CONFLICT MINERALS REPORT OF CAS MEDICAL SYSTEMS, INC. EXHIBIT 1.01 CAS Medical Systems, Inc. Conflict Minerals Report For the reporting period from January 1, 2017 to December 31, 2017 This Conflict Minerals Report (the "Report") of CAS Medical Systems, Inc. and its wholly-owned subsidiary (referred to in this Report as the "Company," "CASMED," "we," "us," or "our") for
May 10, 2018	EX-99.1	CASMED Reports First-Quarter 2018 Financial Results FORE-SIGHT sales increase 22%; U.S. FORE-SIGHT sales increase 21% Company raises 2018 U.S. and international FORE-SIGHT sales guidance Conference Call Begins at 10:00 a.m. Eastern Time Today EXHIBIT 99.1 CASMED Reports First-Quarter 2018 Financial Results FORE-SIGHT sales increase 22%; U.S. FORE-SIGHT sales increase 21% Company raises 2018 U.S. and international FORE-SIGHT sales guidance Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., May 10, 2018 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical products for non-invasive
May 10, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 f8k050918.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 10, 2018 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Inco
May 10, 2018	10-Q	CASM / CAS Medical Systems, Inc. FORM 10Q DATED MARCH 31, 2018 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑Q Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2018 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
May 8, 2018	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2018 CAS MEDICAL SYSTEMS, INC.
May 8, 2018	EX-10.2	Warrant to Purchase Stock dated May 8, 2018 issued to East West Bank EX-10.2 3 ex10-218202.htm WARRANT TO PURCHASE STOCK DATED MAY 8, 2018 ISSUED TO EAST WEST BANK EXHIBIT 10.2 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND
May 8, 2018	EX-10.1	Loan and Security Agreement dated May 8, 2018, between the Company and East West Bank EX-10.1 2 exh10-118202.htm LOAN AND SECURITY AGREEMENT DATED MAY 8, 2018, BETWEEN THE COMPANY AND EAST WEST BANK EXHIBIT 10.1 LOAN AND SECURITY AGREEMENT This LOAN AND SECURITY AGREEMENT (this "Agreement") is entered into as of May 8, 2018, by and between East West Bank ("Bank") and CAS Medical Systems, Inc. ("Borrower"). RECITALS Borrower wishes to obtain credit from time to time from Bank, and B
April 26, 2018	DEFA14A	CASM / CAS Medical Systems, Inc. DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to Rule 14a-12 CAS MEDICAL SYSTEMS, INC.
April 26, 2018	DEF 14A	CASM / CAS Medical Systems, Inc. DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material Pursuant to Rule 14a-12 CAS MEDICAL SYSTEMS, INC.
March 26, 2018	10-K	CASM / CAS Medical Systems, Inc. FORM 10-K -- YEAR ENDED DECEMBER 31, 2017 (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑K Annual Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Fiscal Year ended December 31, 2017 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
March 26, 2018	EX-21.1	Subsidiaries of the Registrant EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT Statcorp, Inc., a Delaware corporation
March 14, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 f8k031318.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 14, 2018 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of In
March 14, 2018	EX-99.1	CASMED Reports 2017 Fourth-Quarter and Full-Year Financial Results U.S. FORE-SIGHT sales increased 18% in Q4 on record 80 placements Conference Call Begins Today at 10:00 a.m. Eastern Time EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 CASMED Reports 2017 Fourth-Quarter and Full-Year Financial Results U.S. FORE-SIGHT sales increased 18% in Q4 on record 80 placements Conference Call Begins Today at 10:00 a.m. Eastern Time BRANFORD, Conn., March 14, 2018 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical products for non-invasive patient monitori
February 14, 2018	SC 13G/A	CASM / CAS Medical Systems, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
February 14, 2018	SC 13G/A	CASM / CAS Medical Systems, Inc. / Long Focus Capital Management, Llc - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* CAS MEDICAL SYSTEMS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 124769209 (CUSIP Number) Long Focus Capital Management LLC 207 Calle Del Parque A&M Tower, 8th Floor San Juan, PR 00912 (787) 333-0240 (Name, Address and Telephone N
February 14, 2018	SC 13G	CASM / CAS Medical Systems, Inc. / ACUTA CAPITAL PARTNERS, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CAS MEDICAL SYSTEMS, INC. (Name of Issuer) COMMON STOCK, PAR $0.004 (Title of Class of Securities) 124769209 (CUSIP Number) ACUTA CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 (Name, Address and Telephone Number of Person Authorize
January 29, 2018	8-K	Other Events 8-K 1 form8k18157.htm FORM 8K DATED JANUARY 26, 2018 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2018 CAS MEDICAL SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdict
January 4, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 f8k010418.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): January 4, 2018 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of I
January 4, 2018	EX-99.1	CASMED Reports Preliminary Net Sales for the 2017 Fourth Quarter U.S. FORE-SIGHT cerebral oximetry sales up 18% for the quarter with record domestic monitor placements EdgarFiling EXHIBIT 99.1 CASMED Reports Preliminary Net Sales for the 2017 Fourth Quarter U.S. FORE-SIGHT cerebral oximetry sales up 18% for the quarter with record domestic monitor placements BRANFORD, Conn., Jan. 04, 2018 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, reports preliminary unaudited topline result
December 1, 2017	SC 13G	CASM / CAS Medical Systems, Inc. / Long Focus Capital Management, Llc - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CAS MEDICAL SYSTEMS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 124769209 (CUSIP Number) Long Focus Capital Management LLC 207 Calle Del Parque A&M Tower, 8th Floor San Juan, PR 00912 (787) 333-0240 (Name, Address and Telephone Numb
November 9, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 f8k110917.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): November 9, 2017 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of
November 9, 2017	EX-99.1	CASMED Reports Third-Quarter 2017 Financial Results Conference Call Begins Today at 10:00 a.m. Eastern Time EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 CASMED Reports Third-Quarter 2017 Financial Results Conference Call Begins Today at 10:00 a.m. Eastern Time BRANFORD, Conn., Nov. 09, 2017 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in non-invasive cerebral oximetry technology, today reported financial results for the three and nine months ended September 30, 2017.
November 9, 2017	10-Q	CASM / CAS Medical Systems, Inc. FORM 10Q - SEPTEMBER 30, 2017 (Quarterly Report) 10-Q 1 form10q18125.htm FORM 10Q - SEPTEMBER 30, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑Q Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2017 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06-112
November 9, 2017	EX-10.1	First Amendment to Loan and Security Agreement, dated November 3, 2017, by and between the Company, Solar Capital Ltd., and Western Alliance Bank (21) EXHIBIT 10.1 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT THIS FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (this "Amendment"), dated as of November 3, 2017 (the "Amendment Effective Date"), is made by and among CAS Medical Systems, Inc., a Delaware corporation ("Borrower"), Solar Capital Ltd., a Maryland corporation ("Solar"), in its capacity as administrative and collateral agent for Lenders
September 22, 2017	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8-K 1 form8k18117.htm FORM 8K DATED SEPTEMBER 22, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2017 CAS MEDICAL SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other juris
August 8, 2017	8-K	CAS Medical Systems FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 8, 2017 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Incorporation) (Commission File
August 8, 2017	EX-99.1	CASMED Reports Second-Quarter 2017 Financial Results Revises Full-year Financial Guidance Conference Call Begins at 10:00 a.m. Eastern Time Today EdgarFiling
August 8, 2017	10-Q	CASM / CAS Medical Systems, Inc. FORM 10Q - JUNE 30, 2017 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑Q Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2017 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
July 26, 2017	EX-99.1	CASMED Sells Non-invasive Blood Pressure Monitoring Product Line to SunTech Medical Marks divestiture of final, non-core legacy assets and allows sole focus on FORE-SIGHT® tissue oximetry products EXHIBIT 99.1 CASMED Sells Non-invasive Blood Pressure Monitoring Product Line to SunTech Medical Marks divestiture of final, non-core legacy assets and allows sole focus on FORE-SIGHT? tissue oximetry products BRANFORD, Conn. (July 26, 2017) ? CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in non-invasive cerebral oximetry technology, announces the sale of its non-invasive blood press
July 26, 2017	EX-2.1	Asset Purchase Agreement dated July 25, 2017, by and between the Company and Suntech Medical Inc. (20) EXHIBIT 2.1 A SSET PURCHASE AGREEMENT BY AND BETWEEN SUNTECH MEDICAL INC. (as " Buyer", on the one hand) AND CAS MEDICAL SYSTEMS, INC. (as " Seller", on the other hand) July 25, 2017 ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT, dated as of July 25, 2017 (this " Agreement"), is by and between SunTech Medical Inc., a North Carolina corporation (" Buyer"), and CAS Medical Systems, Inc., a
July 26, 2017	8-K	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets 8-K 1 form8k18091.htm FORM 8K DATED JULY 25, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2017 CAS MEDICAL SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of
June 22, 2017	8-K	CAS Medical Systems FORM 8K DATED JUNE 21, 2017 (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2017 CAS MEDICAL SYSTEMS, INC.
June 16, 2017	8-K	CAS Medical Systems FORM 8K DATED JUNE 14, 2017 (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2017 CAS MEDICAL SYSTEMS, INC.
May 26, 2017	EX-1.01	CAS Medical Systems, Inc. Conflict Minerals Report For the reporting period from January 1, 2016 to December 31, 2016 EX-1.01 2 exh1-0118079.htm CONFLICT MINERALS REPORT OF CAS MEDICAL SYSTEMS, INC. EXHIBIT 1.01 CAS Medical Systems, Inc. Conflict Minerals Report For the reporting period from January 1, 2016 to December 31, 2016 This Conflict Minerals Report (the "Report") of CAS Medical Systems, Inc. and its wholly-owned subsidiary (referred to in this Report as the "Company," "CASMED," "we," "us," or "our") for
May 26, 2017	SD	CAS Medical Systems CAS MEDICAL SYSTEMS - FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 44 East Industrial Road, Branford, CT 06405 (Address of principal executive
May 10, 2017	10-Q	CAS Medical Systems FORM 10Q - MARCH 31, 2017 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑Q Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2017 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
May 3, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 f8k050317.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 3, 2017 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Incor
May 3, 2017	EX-99.1	CASMED Reports First-Quarter 2017 Financial Results Revises Outlook for Full-year FORE-SIGHT Growth Conference Call Begins at 10:00 a.m. Eastern Time Today EdgarFiling
April 26, 2017	DEFA14A	CAS Medical Systems DEFINITIVE ADDITIONAL MATERIALS t1701134x2-defa14a - none - 1.3661366s ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of Commission Only (as permitted by Rule
April 26, 2017	DEF 14A	CAS Medical Systems DEFINITIVE PROXY STATEMENT t1701134-def14a - none - 3.2133213s UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e
April 4, 2017	SC 13D	CASM / CAS Medical Systems, Inc. / Patton Thomas M - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
March 17, 2017	SC 13G/A	CASM / CAS Medical Systems, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
March 15, 2017	10-K	CAS Medical Systems FORM 10K - DECEMBER 31, 2016 (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10?K Annual Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Fiscal Year ended December 31, 2016 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
March 15, 2017	EX-10.7	Second Amendment to Lease Agreement between CAS Medical Systems, Inc. and Albany Road Branford II LLC, dated January 23, 2017 (22) EXHIBIT 10.7 SECOND AMENDMENT TO LEASE THIS SECOND AMENDMENT TO LEASE (the " Second Amendment") is made as of January 23, 2017, by and between ALBANY ROAD-BRANFORD II LLC, a Delaware limited liability company, as successor-in-interest to DMP New Branford LLC (" Landlord"), having an address of c/o Albany Road Real Estate Partners, LLC, 10 High Street, 7th Floor Boston, Massachusetts 02110 and CAS
March 15, 2017	EX-21.1	SUBSIDIARIES OF THE REGISTRANT EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT Statcorp, Inc., a Delaware corporation
March 9, 2017	EX-99	CASMED Reports 2016 Fourth-Quarter and Full-Year Financial Results FORE-SIGHT® disposable sensor sales increased 22% in 2016 2016 sales up 14% to $22.2 million Conference Call Begins at 10:00 a.m. Eastern Time Today EdgarFiling
March 9, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 f8k030917.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 9, 2017 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Inc
February 16, 2017	SC 13G/A	CASM / CAS Medical Systems, Inc. / ACUTA CAPITAL PARTNERS, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* CAS MEDICAL SYSTEMS, INC. (Name of Issuer) COMMON STOCK, PAR $0.004 (Title of Class of Securities) 124769209 (CUSIP Number) ACUTA CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 (Name, Address and Telephone Number of Person Authoriz
February 14, 2017	SC 13G/A	CASM / CAS Medical Systems, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
February 13, 2017	SC 13G	CASM / CAS Medical Systems, Inc. / ACUTA CAPITAL PARTNERS, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CAS MEDICAL SYSTEMS, INC. (Name of Issuer) COMMON STOCK, PAR $0.004 (Title of Class of Securities) 124769209 (CUSIP Number) ACUTA CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 (Name, Address and Telephone Number of Person Authorize
February 10, 2017	SC 13G/A	CASM / CAS Medical Systems, Inc. / Broadfin Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
January 10, 2017	EX-99.1	CASMED Reports Preliminary Net Sales for the 2016 Fourth Quarter and Full Year FORE-SIGHT Cerebral Oximetry Sales up 17% for the Full Year EdgarFiling
January 10, 2017	8-K	CAS Medical Systems FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): January 10, 2017 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Incorporation) (Commission Fi
January 4, 2017	SC 13D/A	CASM / CAS Medical Systems, Inc. / PESSIN NORMAN H - NORMAN H. PESSIN SC 13DA NO. 3 1-3-2017 (CAS MEDICAL SYSTEMS, INC.) Activist Investment SC 13D/A 1 formsc13da.htm NORMAN H. PESSIN SC 13DA NO. 3 1-3-2017 (CAS MEDICAL SYSTEMS, INC.) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3 )* CAS Medical Systems, Inc. (Name of Issuer) Common Stock, $.004 par value (Title of Class of Securities) 124769 20 9 Cusip Number Norman H. Pessin Brian Pessin
November 29, 2016	424B2	CAS MEDICAL SYSTEMS, INC. COMMON STOCK PREFERRED STOCK WARRANTS UNITS 424B2 1 t1602905-424b2.htm PROSPECTUS TABLE OF CONTENTS Filed pursuant to Rule 424(b)(2) Registration No. 333-214614 PROSPECTUS CAS MEDICAL SYSTEMS, INC. $30,000,000 COMMON STOCK PREFERRED STOCK WARRANTS UNITS We may offer from time to time any combination of the securities described in this prospectus, either individually or in units. This prospectus provides a general description of the secur
November 22, 2016	CORRESP	CAS Medical Systems ESP CAS MEDICAL SYSTEMS, INC. 44 East Industrial Road Branford, CT 06405 203-488-6056 (Phone) November 22, 2016 Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Re: CAS MEDICAL SYSTEMS, INC. (the "Company") Registration Statement on Form S-3 (File No. 333-214614) Ladies and Gentlemen: In connection with the above-captioned Registration Statem
November 15, 2016	S-3	CAS Medical Systems FORM S-3 t1602708-s3 - none - 2.1942194s TABLE OF CONTENTS As filed with the Securities and Exchange Commission on November 15, 2016 Registration No. 333- ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ? FORM S-3 ? REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CAS MEDICAL SYSTEMS, INC. (Exact Name of Registrant as Specified in Its Charter) ? Delaware ? ? 06-1123096 ?
November 8, 2016	10-Q	CAS Medical Systems FORM 10Q - SEPT. 30, 2016 (Quarterly Report) 10-Q 1 form10q17999.htm FORM 10Q - SEPT. 30, 2016 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑Q Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2016 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06-1123096
November 8, 2016	EX-99.1	CASMED Reports Third-Quarter 2016 Financial Results FORE-SIGHT® U.S. disposable sensor revenues up 23%, net 129 FORE-SIGHT cerebral oximeters shipped worldwide Conference Call Begins at 10:00 a.m. ET Today EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 CASMED Reports Third-Quarter 2016 Financial Results FORE-SIGHT® U.S. disposable sensor revenues up 23%, net 129 FORE-SIGHT cerebral oximeters shipped worldwide Conference Call Begins at 10:00 a.m. ET Today BRANFORD, Conn., Nov. 08, 2016 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical products for non-invasive
November 8, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): November 8, 2016 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Incorporation) (Commission Fi
August 9, 2016	S-8	CAS Medical Systems FORM S-8 DATED AUGUST 9, 2016 S-8 1 cas-s817973.htm FORM S-8 DATED AUGUST 9, 2016 As filed with the Securities and Exchange Commission on August 9, 2016 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06-1123096 (State or
August 9, 2016	S-8	CAS Medical Systems FORM S-8 DATED AUGUST 9, 2016 S-8 1 cas-s817973.htm FORM S-8 DATED AUGUST 9, 2016 As filed with the Securities and Exchange Commission on August 9, 2016 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06-1123096 (State or
August 5, 2016	10-Q	CAS Medical Systems (Quarterly Report) 10-Q 1 form10q17968.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑Q Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2016 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06-1123096 (State or other jurisdiction o
August 4, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 4, 2016 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Incorporation) (Commission File
August 4, 2016	EX-99.1	CASMED Reports Second-Quarter 2016 Financial Results FORE-SIGHT® Disposable Sensor Revenues Increase 27% Conference Call Begins at 10:00 a.m. ET Today EdgarFiling
July 5, 2016	EX-10.1	Loan and Security Agreement dated June 30, 2016 by and between the Company, Solar Capital Ltd., and Western Alliance Bank (19) EXHIBIT 10.1 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT, dated as of June 30, 2016 (as amended, restated, supplemented or otherwise modified from time to time, this " Agreement"), is among Solar Capital Ltd., a Maryland corporation (" Solar"), in its capacity as administrative and collateral agent for Lenders (together with its successors and assigns in such capacity, " Agent") a
July 5, 2016	8-K	CAS Medical Systems FORM 8K DATED JUNE 30, 2016 (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2016 CAS MEDICAL SYSTEMS, INC.
July 5, 2016	EX-10.3	Warrant to Purchase Stock, dated June 30, 2016, issued by the Company to Western Alliance Bank (19) EXHIBIT 10.3 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD , PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY,
July 5, 2016	EX-10.2	Warrant to Purchase Stock, dated June 30, 2016, issued by the Company to Solar Capital Ltd. (19) EXHIBIT 10.2 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD , PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY,
June 23, 2016	8-K	CAS Medical Systems FORM 8K DATED JUNE 22, 2016 (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2016 CAS MEDICAL SYSTEMS, INC.
May 27, 2016	EX-1.01	CAS Medical Systems, Inc. Conflict Minerals Report For the reporting period from January 1, 2015 to December 31, 2015 EXHIBIT 1.01 CAS Medical Systems, Inc. Conflict Minerals Report For the reporting period from January 1, 2015 to December 31, 2015 This Conflict Minerals Report (the "Report") of CAS Medical Systems, Inc. and its wholly-owned subsidiary (referred to in this Report as the "Company," "CASMED," "we," "us," or "our") for the reporting period from January 1, 2015 to December 31, 2015 (the "Reporting Pe
May 27, 2016	SD	CAS Medical Systems CAS MEDICAL SYSTEMS - FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 44 East Industrial Road, Branford, CT 06405 (Address of principal executive
May 11, 2016	10-Q	CAS Medical Systems (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10?Q Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2016 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
May 11, 2016	EX-2.1	Asset Purchase Agreement dated March 28, 2016, by and between the Company and Trinity Medical Devices Inc. (18) EXHIBIT 2.1 A SSET PURCHASE AGREEMENT BY AND AMONG TRINITY MEDICAL DEVICES INC. (as " Buyer", on the one hand) AND CAS MEDICAL SYSTEMS, INC. (as " Seller", on the other hand) March 28, 2016 ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT, dated as of March 28, 2016 (this " Agreement"), is by and between Trinity Medical Devices Inc., a Delaware corporation (" Buyer"), and CAS Medical Systems
May 9, 2016	SC 13G/A	CASM / CAS Medical Systems, Inc. / ACUTA CAPITAL PARTNERS, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* CAS MEDICAL SYSTEMS, INC. (Name of Issuer) COMMON STOCK, PAR $0.004 (Title of Class of Securities) 124769209 (CUSIP Number) ACUTA CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 (Name, Address and Telephone Number of Person Authoriz
May 5, 2016	8-K	CAS Medical Systems FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 5, 2016 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Incorporation) (Commission File Nu
May 5, 2016	EX-99.1	CASMED Reports First-Quarter 2016 Financial Results Net sales increase 21%, FORE-SIGHT sales up 31% Conference Call Begins at 10:00 a.m. ET Today EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 CASMED Reports First-Quarter 2016 Financial Results Net sales increase 21%, FORE-SIGHT sales up 31% Conference Call Begins at 10:00 a.m. ET Today BRANFORD, Conn., May 05, 2016 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in non-invasive patient monitoring of cerebral oxygenation, today reported financial results for t
April 26, 2016	DEFA14A	CAS Medical Systems DEFINITIVE ADDITIONAL MATERIALS t1600929x2-defa14a - none - 1.6781678s ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of Commission Only (as permitted by Rule
April 26, 2016	DEF 14A	CAS Medical Systems, Inc. 2011 Equity Incentive Plan, as amended (13) t1600929-def14a - none - 5.1045104s ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of Commission Only (as permitted by Rule 14a
March 30, 2016	10-K	CAS Medical Systems FORM 10-K FOR YEAR END 12/31/15 (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10?K Annual Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Fiscal Year ended December 31, 2015 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
March 30, 2016	EX-21.1	SUBSIDIARIES OF THE REGISTRANT exh21-117781.htm EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT Statcorp, Inc., a Delaware corporation
March 29, 2016	8-K	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2016 CAS MEDICAL SYSTEMS, INC.
March 9, 2016	8-K	CAS Medical Systems FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 9, 2016 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Incorporation) (Commission File
March 9, 2016	EX-99.1	CASMED Reports 2015 Fourth Quarter and Full Year Financial Results Fourth Quarter U.S. FORE-SIGHT Sales Increase 38% and Include 24% Growth in U.S. Disposable Sensor Sales Conference Call Begins at 10:00 a.m. Eastern Time Today EdgarFiling
February 16, 2016	SC 13G/A	CASM / CAS Medical Systems, Inc. / Flynn James E Passive Investment SC 13G/A 1 e614574sc13ga-cas.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1) * CAS Medical Systems, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 124769209 (CUSIP Number) December 3
February 12, 2016	SC 13G/A	CASM / CAS Medical Systems, Inc. / Broadfin Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
February 12, 2016	SC 13G	CASM / CAS Medical Systems, Inc. / ACUTA CAPITAL PARTNERS, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CAS MEDICAL SYSTEMS, INC. (Name of Issuer) COMMON STOCK, PAR $0.004 (Title of Class of Securities) 124769209 (CUSIP Number) ACUTA CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 (Name, Address and Telephone Number of Person Authorize
January 7, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): January 7, 2016 CAS Medical Systems, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 0-13839 06-1123096 (State or Other Jurisdiction of Incorporation) (Commission Fil
January 7, 2016	EX-99.1	CASMED Reports Preliminary Net Sales for the 2015 Fourth Quarter and Full Year FORE-SIGHT Cerebral Oximetry Sales Up 33% for the Quarter EX-99.1 2 exh991.htm EXHIBIT 99.1 EXHIBIT 99.1 CASMED Reports Preliminary Net Sales for the 2015 Fourth Quarter and Full Year FORE-SIGHT Cerebral Oximetry Sales Up 33% for the Quarter BRANFORD, Conn., Jan. 07, 2016 (GLOBE NEWSWIRE) -CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, reports preliminary unaudited top-line results for t
November 9, 2015	SC 13D/A	CAS Medical Systems NORMAN H. PESSIN SC 13DA NO. 2 11-6-2015 (CAS MEDICAL SYSTEMS, INC.) (Activist Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2 )* CAS Medical Systems, Inc. (Name of Issuer) Common Stock, $.004 par value (Title of Class of Securities) 124769 20 9 Cusip Number Norman H. Pessin Brian Pessin 366 Madison Avenue, 14 th Floor New York, NY 10017 212-661-2670 (Name, Address and Telephone N
November 6, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2015 Commission File Number 0-13839 C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2015 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
November 5, 2015	8-K	CAS Medical Systems FORM 8-K FILING DOCUMENT (Current Report/Significant Event) Form 8-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2015 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorpora
November 5, 2015	EX-99	CASMED Reports Third Quarter 2015 Financial Results CASMED Reports Third Quarter 2015 Financial Results EXHIBIT 99.1 CASMED Reports Third Quarter 2015 Financial Results FORE-SIGHT Disposable Sensor Sales Increase 30%, Represent 62% of Net Sales Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Nov. 5, 2015 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient
October 29, 2015	8-K	CAS Medical Systems FORM 8-K DATED OCTOBER 26, 2015 (Current Report/Significant Event) form8-k17863.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2015 CAS MEDICAL SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-13839 (Commi
October 29, 2015	EX-99.1	CASMED Sells Vital Signs Monitoring Line, Tightens Focus on FORE-SIGHT Cerebral Oximetry Business BRANFORD, Conn. (October 29, 2015) – CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, exh99-117863.htm EXHIBIT 99.1 CASMED Sells Vital Signs Monitoring Line, Tightens Focus on FORE-SIGHT Cerebral Oximetry Business BRANFORD, Conn. (October 29, 2015) ? CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the sale of assets related to its 740 SELECT? vital signs monitoring product line to Zoe Medical, Inc. The sa
August 5, 2015	8-K	CAS Medical Systems FORM 8-K FILING DOCUMENT (Current Report/Significant Event) Form 8-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2015 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporati
August 5, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2015 Commission File Number 0-13839 CAS ME UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2015 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
August 5, 2015	EX-99	CASMED Reports Second Quarter 2015 Financial Results CASMED Reports Second Quarter 2015 Financial Results EXHIBIT 99.1 CASMED Reports Second Quarter 2015 Financial Results FORE-SIGHT? Disposable Sensor Revenues Increase 22%, Represent 55% of Total Sales Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Aug. 5, 2015 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive
July 7, 2015	8-K	CAS Medical Systems FORM 8-K DATED JULY 1, 2015 (Current Report/Significant Event) form8-k17827b.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2015 CAS MEDICAL SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-13839 (Commissi
June 25, 2015	EX-24	EX-24 POWER OF ATTORNEY Know all by these presents,that the undersigned hereby constitutes and appoints each of Thomas Patton and Jeffery Baird, signing singly, as the undersigned's true and lawful attorney-in-fact to: 1.
June 25, 2015	8-K	Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders form8-k17827.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2015 CAS MEDICAL SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-13839 (Commissi
June 25, 2015	EX-3.1	Certificate of Amendment to Certificate of Incorporation of the Registrant filed June 23, 2015 (17) exh3-117827.htm EXHIBIT 3.1 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF CAS MEDICAL SYSTEMS, INC. * * * * * * (a Delaware corporation incorporated on December 5, 1984) Pursuant to Section 242 of the General Corporation Law of the State of Delaware, CAS Medical Systems, Inc. (hereinafter called the ?Company? or the ?Corporation?), organized and existing under and by virtue of the Ge
May 29, 2015	SD	CAS Medical Systems UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 44 East Industrial Road, Branford, CT 06405 (Address of principal executive
May 5, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2015 Commission File Number 0-13839 CAS M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2015 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
May 5, 2015	8-K	CAS Medical Systems FORM 8-K FILING DOCUMENT (Current Report/Significant Event) Form 8-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 5, 2015 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporation)
May 5, 2015	EX-99	CASMED Reports First Quarter 2015 Financial Results CASMED Reports First Quarter 2015 Financial Results EXHIBIT 99.1 CASMED Reports First Quarter 2015 Financial Results Conference Call Begins at 10:00 a.m. ET Today BRANFORD, Conn., May 5, 2015 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three months ended March 31, 2015
April 28, 2015	DEF 14A	CAS Medical Systems DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material Pursuant to Rule 14a-12 CAS MEDICAL SYSTEMS, INC.
April 28, 2015	DEFA14A	CAS Medical Systems DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant S Filed by a Party other than the Registrant £ Check the appropriate box: £ Preliminary Proxy Statement £ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)(2)) £ Definitive Proxy Statement S Definitive Additional Materials £ Soliciting Material Pursuant to Rule 14a-12 CAS MEDICAL SYSTEMS, INC.
April 13, 2015	PRE 14A	CAS Medical Systems PRELIMINARY PROXY STATEMENT t1500841-pre14a - none - 4.506s ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e
March 18, 2015	EX-21.1	SUBSIDIARIES OF THE REGISTRANT EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT Statcorp, Inc., a Delaware corporation
March 18, 2015	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year ended December 31, 2014 Commission File Number 0-13839 CAS MEDICA UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year ended December 31, 2014 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
March 4, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 4, 2015 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission Fi
March 4, 2015	EX-99	CASMED Announces 2014 Fourth Quarter and Full Year Financial Results EXHIBIT 99.1 CASMED Announces 2014 Fourth Quarter and Full Year Financial Results FORE-SIGHT® Sales Increase 37% for the Year Conference Call Begins at 10:00 a.m. ET Today BRANFORD, Conn., March 4, 2015 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three and 12 months en
February 27, 2015	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A (Amendment No.
February 19, 2015	SC 13D	CASM / CAS Medical Systems, Inc. / PESSIN NORMAN H - NORMAN H PESSIN SC 13D 2-19-2015 (CAS MEDICAL SYSTEMS, INC) Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* CAS Medical Systems, Inc. (Name of Issuer) Common Stock, $.004 par value (Title of Class of Securities) 124769 20 9 Cusip Number Norman H. Pessin Brian Pessin 366 Madison Avenue, 14th Floor New York, NY 10017 212-661-2670 (Name, Address and Telephone Numb
February 17, 2015	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2015 CAS MEDICAL SYSTEMS, INC.
February 17, 2015	SC 13G/A	CASM / CAS Medical Systems, Inc. / Broadfin Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
February 11, 2015	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2015 CAS MEDICAL SYSTEMS, INC.
February 11, 2015	EX-99.1	CAS MEDICAL SYSTEMS Announces PRICING OF PUBLIC OFFERING OF COMMON STOCK Exhibit 99.1 CAS MEDICAL SYSTEMS Announces PRICING OF PUBLIC OFFERING OF COMMON STOCK BRANFORD, Conn. (February 11, 2015) – CAS Medical Systems, Inc. (“CASMED” or the “Company”) (NASDAQ: CASM), a medical technology company that develops, manufactures and markets non-invasive patient monitoring products, today announced that it has priced a firm commitment underwritten public offering of 6,200,000
February 11, 2015	EX-1.1	6,200,000 Firm Shares Up to 930,000 Option Shares CAS Medical Systems, Inc. Common Stock, $0.004 par value PURCHASE AGREEMENT EXHIBIT 1.1 6,200,000 Firm Shares Up to 930,000 Option Shares CAS Medical Systems, Inc. Common Stock, $0.004 par value PURCHASE AGREEMENT February 11, 2015 Craig-Hallum Capital Group LLC As Representative of the Several Underwriters Identified in Schedule I Annexed Hereto 222 South Ninth Street, Suite 350 Minneapolis, Minnesota 55402 Ladies and Gentlemen: CAS Medical Systems, Inc., a Delaware corp
February 11, 2015	424B2	6,200,000 Shares CAS MEDICAL SYSTEMS, INC. Common Stock $1.30 per share TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(2) Registration No. 333-188844 Prospectus Supplement (To the Prospectus dated May 24, 2013) 6,200,000 Shares CAS MEDICAL SYSTEMS, INC. Common Stock $1.30 per share We are offering 6,200,000 shares of our common stock. Our common stock is listed on The Nasdaq Capital Market under the symbol “CASM.” On February 10, 2015, the last reported sale pric
February 4, 2015	EX-99.1	CAS MEDICAL SYSTEMS Announces proposed public offering of common stock Exhibit 99.1 CAS MEDICAL SYSTEMS Announces proposed public offering of common stock BRANFORD, Conn. (February 4, 2015) – CAS Medical Systems, Inc. (“CASMED” or the “Company”) (NASDAQ: CASM), a medical technology company that develops, manufactures and markets non-invasive patient monitoring products, today announced that it intends to offer $8.0 million worth of its common stock in an underwritten
February 4, 2015	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2015 CAS MEDICAL SYSTEMS, INC.
February 4, 2015	424B5	Subject to completion, dated February 4, 2015 TABLE OF CONTENTS The information in this preliminary prospectus supplement is not complete and may be changed.
January 8, 2015	EX-99.1	CASMED Appoints Paul Molloy to its Board of Directors Medical device industry veteran brings more than 20 years of executive management and operations experience, increases the size of the Board to six Directors EXHIBIT 99.1 CASMED Appoints Paul Molloy to its Board of Directors Medical device industry veteran brings more than 20 years of executive management and operations experience, increases the size of the Board to six Directors BRANFORD, Conn. (January 5, 2015) – CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the appointme
January 8, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2015 CAS MEDICAL SYSTEMS, INC.
January 8, 2015	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A (Amendment No.
January 7, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 7, 2015 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission
January 7, 2015	EX-99	CASMED Reports Preliminary Sales for the 2014 Fourth Quarter and Full Year EXHIBIT 99.1 CASMED Reports Preliminary Sales for the 2014 Fourth Quarter and Full Year Marks Fifth Consecutive Quarter Placing 90 or More FORE-SIGHT(R) Cerebral Oximeter Monitors BRANFORD, Conn., Jan. 7, 2015 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, reports preliminary unaudited top-line results for the f
November 4, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2014 Commission File Number 0-13839 C 10-Q 1 form10-q17718.htm FORM 10-Q DATED SEPTEMBER 30, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2014 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 0
November 4, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 4, 2014 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission
November 4, 2014	EX-99	CASMED Announces Third Quarter 2014 Financial Results EXHIBIT 99.1 CASMED Announces Third Quarter 2014 Financial Results FORE-SIGHT® Sales Increase 55%, Operating Loss Narrows Substantially Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Nov. 4, 2014 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the thr
October 9, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2014 CAS MEDICAL SYSTEMS, INC.
August 8, 2014	S-8	CASM / CAS Medical Systems, Inc. S-8 - - FORM S-8 As filed with the Securities and Exchange Commission on August 8, 2014 Registration Statement No.
August 6, 2014	EX-99	CASMED Announces Second Quarter 2014 Financial Results EXHIBIT 99.1 CASMED Announces Second Quarter 2014 Financial Results FORE-SIGHT® Sales Increase 48%, Now Represent 56% of Net Sales Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Aug. 6, 2014 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three mo
August 6, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 6, 2014 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission F
August 6, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2014 Commission File Number 0-13839 CAS ME UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2014 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
July 2, 2014	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2014 CAS MEDICAL SYSTEMS, INC.
June 30, 2014	EX-10.2	Warrant to Purchase Stock, dated June 27, 2014, issued by the Company to GE Capital Equity Investments, Inc. (16) EXHIBIT 10.2 WARRANT NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUBJECT TO SECTION 6 BELOW, AND EXCEPT IN COMPLIANCE WITH RULE 144 UNDER SAID ACT, NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL FOR HOLDER, SATISFACTORY T
June 30, 2014	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2014 CAS MEDICAL SYSTEMS, INC.
June 30, 2014	EX-10.1	LOAN AND SECURITY AGREEMENT EXHIBIT 10.1 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT, dated as of June 27, 2014 (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), is among General Electric Capital Corporation (“GECC”), in its capacity as administrative and collateral agent for Lenders (together with its successors and assigns in such capacity, “Agent”), the financ
June 27, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2014 CAS MEDICAL SYSTEMS, INC.
June 2, 2014	SC 13D	CASM / CAS Medical Systems, Inc. / PESSIN NORMAN H - NORMAN PESSIN SC 13D 5-30-2014 (CAS MEDICAL SYSTEMS) Activist Investment SC 13D 1 formsc13d.htm NORMAN PESSIN SC 13D 5-30-2014 (CAS MEDICAL SYSTEMS) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* CAS Medical Systems, Inc. (Name of Issuer) Common Stock, $.004 par value (Title of Class of Securities) 124769 20 9 Cusip Number Norman H. Pessin Brian Pessin 366 Madison Avenue,
May 30, 2014	SD	- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 44 East Industrial Road, Branford, CT 06405 (Address of principal executive
May 2, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2014 Commission File Number 0-13839 CAS M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2014 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
May 1, 2014	EX-99	CASMED Announces First Quarter 2014 Financial Results EXHIBIT 99.1 CASMED Announces First Quarter 2014 Financial Results FORE-SIGHT® Sales Increase 24% Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., May 1, 2014 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three months ended March 31, 2014. Net sal
May 1, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 1, 2014 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission File
April 29, 2014	DEF 14A	- DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material Pursuant to Rule 14a-12 CAS MEDICAL SYSTEMS, INC.
April 29, 2014	DEFA14A	- DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant S Filed by a Party other than the Registrant £ Check the appropriate box: £ Preliminary Proxy Statement £ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)(2)) £ Definitive Proxy Statement S Definitive Additional Materials £ Soliciting Material Pursuant to Rule 14a-12 CAS MEDICAL SYSTEMS, INC.
March 19, 2014	EX-21.1	SUBSIDIARIES OF THE REGISTRANT EX-21.1 4 exh21-117631.htm SUBSIDIARIES OF THE REGISTRANT EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT Statcorp, Inc., a Delaware corporation
March 19, 2014	EX-10.30	THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-10.30 3 exh10-3017631.htm THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT EXHIBIT 10.30 THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT This Third Amendment to Loan and Security Agreement (this “Amendment”) is entered into as of March 17, 2014, by and between EAST WEST BANK (“Bank”) and CAS Medical Systems, Inc. (“Borrower”). RECITALS Borrower and Bank are parties to that certain Loan and Securit
March 19, 2014	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year ended December 31, 2013 Commission File Number 0-13839 CAS MEDICA 10-K 1 form10-k17631.htm FORM 10-K DATED 12/31/13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year ended December 31, 2013 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06-1123096 (State or
March 19, 2014	EX-10.29	EMPLOYMENT AGREEMENT EX-10.29 2 exh10-2917631.htm EMPLOYMENT AGREEMENT EXHIBIT 10.29 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT, entered into as of October 2, 2013, by and between CAS Medical Systems, Inc., a Delaware corporation (the "Company", which term includes any successor to CAS Medical Systems, Inc., by merger or otherwise), and Brian J. Wagner (the "Employee.") WITNESSETH: WHEREAS, the Company desires to
March 17, 2014	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - FORM 8-K DATED MARCH 17, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2014 CAS MEDICAL SYSTEMS, INC.
March 6, 2014	EX-99	CASMED Announces Fourth Quarter and Full-Year 2013 Financial Results EXHIBIT 99.1 CASMED Announces Fourth Quarter and Full-Year 2013 Financial Results Fourth Quarter U.S. FORE-SIGHT® Disposable Sales Increase 35% Conference Call Begins at 10:00 a.m. ET Today BRANFORD, Conn., March 6, 2014 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the thre
March 6, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 6, 2014 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission Fi
February 14, 2014	SC 13G/A	CASM / CAS Medical Systems, Inc. / Broadfin Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
January 9, 2014	8-K/A	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A (Amendment No.
January 8, 2014	EX-99	CASMED Reports Preliminary Sales for Fourth Quarter and Full Year 2013 EXHIBIT 99.1 CASMED Reports Preliminary Sales for Fourth Quarter and Full Year 2013 Places 90 FORE-SIGHT(R) Cerebral Oximeter Monitors During the Quarter BRANFORD, Conn., Jan. 8, 2014 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported preliminary top-line unaudited results for the fourth quarter and f
January 8, 2014	8-K	Financial Statements and Exhibits, Other Events - FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 8, 2014 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission
November 12, 2013	EX-99	CASMED Announces Third Quarter 2013 Financial Results EXHIBIT 99.1 CASMED Announces Third Quarter 2013 Financial Results Launch of Next-Generation Cerebral Oximetry Products Underway Conference Call Begins at 10:00 a.m. ET Today BRANFORD, Conn., Nov. 12, 2013 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three and nine mont
November 12, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2013 Commission File Number 0-13839 C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2013 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
November 12, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 12, 2013 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commissio
October 3, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K DATED OCTOBER 2, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2013 CAS MEDICAL SYSTEMS, INC.
October 3, 2013	EX-99.1	CASMED Names Brian Wagner as Chief Commercial Officer EXHIBIT 99.1 CASMED Names Brian Wagner as Chief Commercial Officer BRANFORD, Conn. (October 2, 2013) – CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it has named Brian J. Wagner as Chief Commercial Officer, effective immediately. Mr. Wagner has 20 years of general management, business development, sales, and mark
September 18, 2013	SC 13G	CASM / CAS Medical Systems, Inc. / Broadfin Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
August 13, 2013	S-8	- FORM S-8 As filed with the Securities and Exchange Commission on August 13, 2013 Registration Statement No.
August 7, 2013	EX-10.2	Employment Agreement with Paul Benni dated May 1, 2008 (15) EXHIBIT 10.2 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT, entered into this 1st day of May, 2008, by and between CAS Medical Systems, Inc., a Delaware corporation (the ?Company?), and Paul Benni (hereinafter called the ?Employee?). WITNESSETH: WHEREAS, the Company desires that the Employee serve as Chief Scientific Officer of the Company and the Employee is willing to serve the Company in such
August 7, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 7, 2013 CAS Medical Systems, Inc. (Exact name of registrant as specified in its charter) DELAWARE 0-13839 06-1123096 (State or other jurisdiction of incorporation) (Commission F
August 7, 2013	EX-99	CASMED Announces Second Quarter 2013 Financial Results EX-99 2 newsrelease.htm PRESS RELEASE EXHIBIT 99.1 CASMED Announces Second Quarter 2013 Financial Results Launch of Next-Generation Vital Signs Monitor Underway Conference Call Begins at 10:00 a.m. ET Today BRANFORD, Conn., Aug. 7, 2013 (GLOBE NEWSWIRE) - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial resu
August 7, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2013 Commission File Number 0-13839 CAS ME UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2013 Commission File Number 0-13839 CAS MEDICAL SYSTEMS, INC.
August 7, 2013	EX-10.1	Employment Agreement with John K. Gamelin dated August 5, 2013 (15) EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT, entered into as of August 5, 2013, by and between CAS Medical Systems, Inc., a Delaware corporation (the "Company", which term includes any successor to CAS Medical Systems, Inc., by merger or otherwise), and John K. Gamelin (the "Employee.") WITNESSETH: WHEREAS, the Company has appointed Employee to serve as Vice President of Research a

CASM / CAS Medical Systems, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)